IDH1 and cancer: The IDH1/2 mutations are frequent events in certain cancers such as lower grade gliomas14–17 where they also overlap with inactivating mutations in ATRX14–17, a chromatin remodeller which deposits histone H3.3 at heterochromatin18–20.